Yield10 Bioscience Executives
| YTENDelisted Stock | USD 1.90 0.04 2.06% |
Yield10 Bioscience employs about 29 people. The company is managed by 6 executives with a total tenure of roughly 32 years, averaging almost 5.0 years of service per executive, having 4.83 employees per reported executive. Analysis of Yield10 Bioscience's management performance can provide insight into the firm performance.
| Oliver Peoples CEO President CEO, Director |
| Lynne Brum President Vice President - Planning and Communications |
Yield10 |
Yield10 Bioscience Management Team Effectiveness
The company has return on total asset (ROA) of (1.5028) % which means that it has lost $1.5028 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (15.0809) %, meaning that it created substantial loss on money invested by shareholders. Yield10 Bioscience's management efficiency ratios could be used to measure how well Yield10 Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Yield10 Bioscience Workforce Comparison
Yield10 Bioscience is rated first in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 100,067. Yield10 Bioscience adds roughly 29.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Yield10 Bioscience Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Yield10 Bioscience insiders, such as employees or executives, is commonly permitted as long as it does not rely on Yield10 Bioscience's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Yield10 Bioscience insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Yield10 Bioscience Notable Stakeholders
A Yield10 Bioscience stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Yield10 Bioscience often face trade-offs trying to please all of them. Yield10 Bioscience's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Yield10 Bioscience's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Oliver Peoples | President CEO, Director | Profile | |
| Lynne Brum | Vice President - Planning and Communications | Profile | |
| Kristi Snell | Chief Science Officer, Vice President - Research | Profile | |
| Charles Haaser | Chief Accounting Officer, Vice President - Finance | Profile | |
| Nicholas Renegar | Director Operations | Profile | |
| ScD Sinskey | CoFounder Director | Profile |
About Yield10 Bioscience Management Performance
The success or failure of an entity such as Yield10 Bioscience often depends on how effective the management is. Yield10 Bioscience management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Yield10 management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Yield10 management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts. Yield10 Bioscience operates under Agricultural Inputs classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.
Yield10 Bioscience Workforce Analysis
Traditionally, organizations such as Yield10 Bioscience use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Yield10 Bioscience within its industry.Yield10 Bioscience Manpower Efficiency
Return on Yield10 Bioscience Manpower
| Revenue Per Employee | 2.1K | |
| Revenue Per Executive | 10K | |
| Net Loss Per Employee | 498.4K | |
| Net Loss Per Executive | 2.4M |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Yield10 Stock
If you are still planning to invest in Yield10 Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Yield10 Bioscience's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |